Skip to main content

Is britishbiosimilars.co.uk a Scam? Security Check Results - British Generic Manufacturers Association Ltd trading as Medicines UK

britishbiosimilars.co.uk Security Report Summary

britishbiosimilars.co.uk received a security score of 39 out of 100 in Guard's comprehensive security analysis, classified as "Potentially Unsafe". This report covers British Generic Manufacturers Association Ltd trading as Medicines UK's website security posture. British Generic Manufacturers Association Ltd trading as Medicines UK operates in the Healthcare industry in United Kingdom.

Medicines UK, operating as the British Generic Manufacturers Association Ltd, is a UK-based trade association focused on the generic and biosimilar medicines sector. Their British Biosimilars Association (BBA) sector group promotes access to high quality biosimilar medicines, collaborating with healthcare professionals, regulators, and the NHS to support sustainable use and education. The website content is professional and targeted at healthcare stakeholders and patients interested in biosimilars. The technical infrastructure relies on legacy JavaScript libraries such as jQuery 1.11.3 and jQuery UI 1.11.4, with additional UI components like Swiper and Magnific Popup. The site is moderately optimized for mobile and performance but lacks modern CMS or advanced frameworks. No forms or analytics scripts were detected, indicating a low data collection footprint. Security posture is moderate with HTTPS implied but no explicit security headers detected in the provided data. The absence of WHOIS domain registration data is a concern for transparency and trust, although the website content and business information appear legitimate. Privacy compliance is partial, with a privacy policy present but no cookie consent mechanism visible. Overall, the website presents a professional front for a healthcare trade association but would benefit from improved domain transparency, enhanced security headers, and stronger privacy compliance measures.

The security scan identified 31 findings across security headers, SSL/TLS, DNS health, email security, GDPR compliance, and NIS2 compliance analysis modules.

Technologies detected: jQuery 1.11.3, jQuery UI 1.11.4, Swiper, Magnific Popup, Google Fonts (Playfair).

About this security scan

Guard performs automated security assessments of websites by analyzing SSL/TLS certificates, HTTP security headers, DNS configuration, email authentication protocols (SPF, DKIM, DMARC), GDPR compliance indicators, NIS2 directive compliance, network exposure, and AI-powered business intelligence. Each report provides domain-specific findings, risk scores, and actionable recommendations.

B

Is britishbiosimilars.co.uk Safe? Security Analysis for British Generic Manufacturers Association Ltd trading as Medicines UK

https://britishbiosimilars.co.uk

Check if britishbiosimilars.co.uk is a scam or legitimate. Free security scan and reviews.

HealthcareUnited Kingdommedium
jQuery 1.11.3jQuery UI 1.11.4SwiperMagnific PopupGoogle Fonts (Playfair)
Analyzed 9/7/2025Completed 9:26:29 AM7mo ago
39
Security Score
HIGH RISK

Below Healthcare avg (65)

10,000+

Domains scanned

500+

Security teams trust us

EveryPay

Secure checkout

Instant

Reports delivered

Professional PDF & Marketing Data

Get the professional PDF report for britishbiosimilars.co.uk

Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.

PDF Report & Export

PDF download, email delivery, unlock code

39.90 €one-time • Incl. 21% VAT

Marketing Intelligence

Contact emails, phone numbers & warm leads

49.90 €one-time • Incl. 21% VAT

Plan Comparison

FeaturePDF ReportMarketing+
Full security analysis
Professional PDF export
Email delivery
Lifetime access + unlock code
Contact emails & phones
Marketing outreach data

Already purchased?

Order summary

Domainbritishbiosimilars.co.uk
Access tierFull report or marketing add-on

Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.

VisaMastercardApple PayGoogle Pay

Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.

SEQ SIA

Lastadijas 12 k-3, Riga, Latvia, LV-1050

Reg. No. 40203410806 • VAT LV40203410806

Support: guard@offseq.com+371 2256 5353

AI Summary

Medicines UK, operating as the British Generic Manufacturers Association Ltd, is a UK-based trade association focused on the generic and biosimilar medicines sector. Their British Biosimilars Association (BBA) sector group promotes access to high quality biosimilar medicines, collaborating with healthcare professionals, regulators, and the NHS to support sustainable use and education. The website content is professional and targeted at healthcare stakeholders and patients interested in biosimilars. The technical infrastructure relies on legacy JavaScript libraries such as jQuery 1.11.3 and jQuery UI 1.11.4, with additional UI components like Swiper and Magnific Popup. The site is moderately optimized for mobile and performance but lacks modern CMS or advanced frameworks. No forms or analytics scripts were detected, indicating a low data collection footprint. Security posture is moderate with HTTPS implied but no explicit security headers detected in the provided data. The absence of WHOIS domain registration data is a concern for transparency and trust, although the website content and business information appear legitimate. Privacy compliance is partial, with a privacy policy present but no cookie consent mechanism visible. Overall, the website presents a professional front for a healthcare trade association but would benefit from improved domain transparency, enhanced security headers, and stronger privacy compliance measures.

Detected Technologies

jQuery 1.11.3jQuery UI 1.11.4SwiperMagnific PopupGoogle Fonts (Playfair)

12 urgent findings need attention

1 critical · 11 high

  • + 4 more findings in the full report below
Continuous monitoring

Keep britishbiosimilars.co.uk under constant watch

Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.

Security drift alerts

Risk score drops, new high-severity issues, and header hardening gaps

Compliance watch

GDPR / NIS2 posture changes with governance evidence snapshots

Infrastructure surface

Unexpected open services, SSL expiry, DNS & email authentication changes

Content & tracker intelligence

Marketing tech shifts, analytics drift, and AI recommendation updates

25 €
per month · billed securely via EveryPay
Less than 1 € / day — cheaper than a single incident response hour

Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.

Purchase to access the monitoring timeline, JSON diffs, alert history, and PDF export for britishbiosimilars.co.uk.

Security Headers

8 findings

15/100

GDPR Compliance

4 findings

53/100

NIS2 Compliance

9 findings

2/100

Email Security

4 findings

70/100

🧠AI Business Intelligence

Technology stack, business insights, and market analysis powered by AI.

Business Intelligence

Market & Strategic Analysis

Medicines UK holds a significant position as a trade association representing generic and biosimilar medicine manufacturers in the UK. Their BBA sector group specializes in biosimilars, a growing segment in healthcare. The business model centers on advocacy, education, and industry collaboration rather than direct commercial sales. Their target customers include healthcare professionals, regulators, and NHS stakeholders. The association leverages partnerships with government bodies and industry groups to influence policy and market access. The website content and external links to authoritative sources like NHS England and IQVIA reinforce their credibility and sector expertise. Growth indicators include active collaboration and educational outreach, though no direct revenue streams are visible on the site.

Extracted Contact Information

Marketing Intelligence Data

Company Registration

Legal Name:

British Generic Manufacturers Association Ltd trading as Medicines UK

Registration Number:

10276727

Security Posture Analysis

Comprehensive Security Assessment

The website demonstrates a moderate security maturity level. HTTPS is used, but no explicit security headers such as Content-Security-Policy or HSTS were detected, which are recommended best practices. The absence of forms reduces attack vectors, but the use of older JavaScript libraries could pose vulnerabilities if not patched. No incident response or security policy information is published, limiting transparency on security governance. Privacy compliance is partial, with a privacy policy present but no cookie consent mechanism. The missing WHOIS data reduces domain trustworthiness and transparency. Overall, the site is functional and professional but could improve in security hardening and compliance documentation.

Strategic Recommendations

Priority Actions for Security Improvement

1

Implement and verify security headers including Content-Security-Policy, X-Frame-Options, and HSTS to enhance protection against common web attacks.

Observations

AI-powered comprehensive website and business analysis.

AI-Enhanced Website Analysis

Business Insights

Company:

British Generic Manufacturers Association Ltd trading as Medicines UK

Description:

Medicines UK is a trade association representing manufacturers of generic and biosimilar medicines in the UK. The British Biosimilars Association (BBA) is a sector group of Medicines UK focused exclusively on biosimilars, promoting access to high quality, safe, and effective biosimilar medicines for UK patients. They collaborate with patients, healthcare professionals, regulators, and the NHS to increase understanding and support sustainable development and use of biosimilars.

Key Services:
Industry representationEducation and awareness on biosimilarsPolicy advocacyCollaboration with healthcare and regulatory bodies
Content Quality:

good

Branding:

consistent

Technical Stack

Technologies:
jQuery 1.11.3jQuery UI 1.11.4SwiperMagnific PopupGoogle Fonts (Playfair)
Performance:

moderate

Mobile:

good

Accessibility:

basic

SEO:

basic

Security Assessment

Security Score:
70/100
Best Practices:
  • HTTPS usage implied by base_url https
  • No forms detected on page reducing input attack surface

Analytics & Tracking

Tracking Level:minimal
Privacy Compliance:basic

Advertising & Marketing

Transparency Level:poor

Website Quality Assessment

Design Quality:good
User Experience:good
Content Relevance:good
Navigation Clarity:good
Professionalism:good
Trustworthiness:high

Key Observations

1

Website is fully accessible with no blocking or WAF challenges.

Get this report delivered to your inbox

Receive a summary of the britishbiosimilars.co.uk security findings by email. Quick and easy to share with decision makers.

🛡️Security Headers

HTTP security headers analysis and recommendations.

Security Headers

HTTP security headers analysis

15/100
Score

Missing Strict-Transport-Security header

HIGH

Forces HTTPS connections

Missing X-Frame-Options header

HIGH

Prevents clickjacking attacks

Missing X-Content-Type-Options header

MEDIUM

Prevents MIME type sniffing

Missing Content-Security-Policy header

HIGH

Controls resources the browser is allowed to load

Missing X-XSS-Protection header

MEDIUM

Legacy XSS protection (deprecated but still recommended)

Missing Referrer-Policy header

LOW

Controls referrer information sent with requests

Missing Permissions-Policy header

MEDIUM

Controls browser features and APIs

Sensitive data may be cached

LOW

Cache-Control header should include "no-store" for sensitive pages

👤GDPR Compliance

Privacy and data protection assessment under GDPR regulations.

GDPR Compliance

Privacy and data protection assessment

53/100
Score

No Cookie Policy found

HIGH

GDPR requires clear information about cookie usage

No Cookie Consent Banner found

HIGH

GDPR requires explicit consent for non-essential cookies

No Data Protection Officer mentioned

LOW

Large organizations may need to designate a DPO under GDPR

Privacy policy may not be GDPR compliant

MEDIUM

Privacy policy lacks explicit GDPR compliance elements

GDPR Compliance Analysis

Privacy Policy85% confidence
Cookie Policy0% confidence
Contact Information Found90% confidence
emailphone

🛡️NIS2 Compliance

Network & Information Security Directive compliance assessment.

NIS2 Compliance

Network & Information Security Directive

2/100
Score

No information security framework found

HIGH

NIS2 requires documented cybersecurity and information security measures

No vulnerability disclosure policy

MEDIUM

NIS2 encourages coordinated vulnerability disclosure

No security policy documentation found

HIGH

NIS2 requires documented cybersecurity governance and risk management

No incident response procedures found

HIGH

NIS2 requires documented incident response and business continuity plans

No business continuity planning found

MEDIUM

NIS2 emphasizes operational resilience and business continuity

No security contact information

HIGH

NIS2 requires clear incident reporting channels

No vulnerability reporting mechanism

MEDIUM

Clear vulnerability reporting supports coordinated disclosure

No NIS2 reference found

LOW

Consider explicitly mentioning NIS2 compliance efforts

Critical sector without clear security compliance

HIGH

Detected sectors: transport, health, digital

Need this report as a PDF?

Download the complete britishbiosimilars.co.uk security analysis as a professional PDF. Share it with your team, clients, or stakeholders.

📧Email Security

SPF, DKIM, and DMARC validation and email security assessment.

Email Security

SPF, DKIM, and DMARC validation

70/100
Score

No DKIM record found

MEDIUM

DKIM adds cryptographic signatures to emails

No BIMI Record

LOW

BIMI displays brand logos in email clients

No MTA-STS Policy

MEDIUM

MTA-STS enforces TLS for email delivery

No TLS-RPT Record

LOW

TLS-RPT provides reporting for email TLS issues

SPF
Sender Policy Framework
DKIM
DomainKeys Identified Mail
DMARC
Domain-based Message Authentication
MX Records
Mail Exchange Records
BIMI
Brand Indicators
MTA-STS
Mail Transfer Agent Security
TLS-RPT
TLS Reporting
DNSSEC
DNS Security
SPF Details
Record:
v=spf1 include:spf.protection.outlook.com -all
DNS Lookups:1/10
Policy:-all

🏆SSL/TLS Security

Certificate validity and encryption analysis.

SSL/TLS Security

Certificate validity and encryption analysis

0/100
Score

Unable to retrieve SSL certificate

CRITICAL

Could not establish secure connection to retrieve certificate information

Mixed Content Detected

MEDIUM

2 resources loaded over insecure HTTP

OCSP Status

OCSP Stapling Disabled

📊DNS Health

DNS configuration and security assessment.

DNS Health

DNS configuration and security assessment

75/100
Score

DNSSEC Not Enabled

MEDIUM

DNSSEC is not configured for this domain

CAA Records Not Configured

LOW

Certificate Authority Authorization (CAA) records not found

No DMARC Record

MEDIUM

DMARC policy not configured

DNS Records

A Records:213.246.109.33
Name Servers:
ns35.domaincontrol.comDNS only
ns36.domaincontrol.comDNS only
MX Records:
0: medicinesuk-com.mail.protection.outlook.com
SOA:Serial: 2025042800, TTL: 600s

DNSSEC Status

DNSSEC Not Enabled

DNS Performance

Resolution Time:219ms

SPF Analysis

SPF Record:
v=spf1 include:spf.protection.outlook.com -all

Network Security

Port scanning and network exposure analysis.

Network Security

Port scanning and network exposure analysis

20/100
Score

High-Risk Service Exposed: FTP

HIGH

Port 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer

How does britishbiosimilars.co.uk compare?

britishbiosimilars.co.uk scores below average. Browse similar domains to see how competitors handle security.

🔧Technical Analysis

Detailed technical findings and analysis from AI assessment.

Technical Analysis

Comprehensive security assessment findings

Additional Findings

The website uses a traditional front-end stack with jQuery 1.11.3 and jQuery UI 1.11.4, which are outdated and may have security vulnerabilities if not maintained. Additional UI libraries include Swiper for sliders and Magnific Popup for modals. Google Fonts are used for typography. The site does not appear to use a modern CMS or JavaScript framework. Performance is moderate with no explicit optimization indicators. Mobile responsiveness is good based on viewport meta tags and CSS usage. SEO is basic with minimal meta description and keywords. No analytics or tracking scripts were detected, indicating minimal user tracking. The site lacks modern security headers and cookie consent mechanisms, which are areas for improvement.
Professional PDF & Marketing Data

Download the britishbiosimilars.co.uk report as PDF

Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.

PDF Report & Export

PDF download, email delivery, unlock code

39.90 €one-time • Incl. 21% VAT

Marketing Intelligence

Contact emails, phone numbers & warm leads

49.90 €one-time • Incl. 21% VAT

Plan Comparison

FeaturePDF ReportMarketing+
Full security analysis
Professional PDF export
Email delivery
Lifetime access + unlock code
Contact emails & phones
Marketing outreach data

Already purchased?

Order summary

Domainbritishbiosimilars.co.uk
Access tierFull report or marketing add-on

Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.

VisaMastercardApple PayGoogle Pay

Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.

SEQ SIA

Lastadijas 12 k-3, Riga, Latvia, LV-1050

Reg. No. 40203410806 • VAT LV40203410806

Support: guard@offseq.com+371 2256 5353

Want OffSeq to fix this?

Book a 30-minute remediation call

Our security engineers can resolve the high-severity findings identified in this report — from SSL misconfigurations and missing headers to compliance gaps and infrastructure hardening.

OffSeq provides end-to-end cybersecurity services: penetration testing, vulnerability remediation, compliance consulting, and continuous monitoring. View all services

Scan your own website

Liked the britishbiosimilars.co.uk report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.

Or browse our directory of >10,000 scanned websites.

⭐ Verified Community Reviews

What others say about britishbiosimilars.co.uk

Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

out of 5

0 reviews published

Loading reviews…

How did we do?

Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.

Analyze Another Website